Digital Tracking of Physical Activity, Heart Rate, and Inhalation Behavior in Patients With Pulmonary Arterial Hypertension Treated With Inhaled Iloprost: Observational Study (VENTASTEP)
BackgroundPulmonary arterial hypertension restricts the ability of patients to perform routine physical activities. As part of pulmonary arterial hypertension treatment, inhaled iloprost can be administered via a nebulizer that tracks inhalation behavior. Pulmonary arterial hypertension treatment is...
Saved in:
Main Authors: | Barbara Stollfuss (Author), Manuel Richter (Author), Daniel Drömann (Author), Hans Klose (Author), Martin Schwaiblmair (Author), Ekkehard Gruenig (Author), Ralf Ewert (Author), Martin C Kirchner (Author), Frank Kleinjung (Author), Valeska Irrgang (Author), Christian Mueller (Author) |
---|---|
Format: | Book |
Published: |
JMIR Publications,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of inhaled iloprost on gas exchange in inhalation injury
by: Andrea Sikora Newsome, et al.
Published: (2017) -
Inhaled iloprost for the treatment of patient with Fontan circulation
by: Yong Hyun Kim, et al.
Published: (2014) -
Inhaled iloprost as part of combination therapy for persistent pulmonary hypertension of the newborn
by: Heru Samudro, et al.
Published: (2012) -
Inhaled Iloprost as a First-Line Therapy for Persistent Pulmonary Hypertension of the Newborn
by: Seung Hyun Kim, et al.
Published: (2019) -
Safety and Tolerability of Continuous Inhaled Iloprost Therapy for Severe Pulmonary Hypertension in Neonates and Infants
by: Amit V. Krishnan, et al.
Published: (2024)